Study of pneumonia patients: clinical features and outcomes
Part of Infections, Lungs & breathing clinical trials.
This is a retrospective study (looking back at past patient records) of people hospitalized with pneumonia to understand how the disease progresses and what factors affect recovery. Researchers will examine medical records of pneumonia patients admitted within 72 hours of symptom onset to identify patterns in who recovers well and who develops serious complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You were diagnosed with pneumonia (sudden illness with new lung shadows on chest imaging)
- You had a positive test confirming the infection-causing germ (bacteria, virus, or fungus)
- You were admitted to the hospital within 72 hours of when symptoms started
- Your medical records from that hospital stay are complete and available
- Your pneumonia was the main reason for admission (not a side effect of another disease like cancer or blood clots)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study observes patients with pneumonia to better understand which patients become very sick and what happens to them over time. Researchers will collect information about your symptoms, test results, and how you recover to help doctors predict outcomes and improve care.
This study follows how community-acquired pneumonia progresses in hospitalized patients who already have serious health problems or weakened immune systems. The goal is to better understand risk and changes over time, which may help guide future care for people like you.
This study follows people who are admitted to a respiratory intensive care unit (a special ICU for breathing problems) because they have pneumonia. It may help doctors better understand pneumonia in ICU patients and improve care in the future.
This study tests a pneumococcal vaccine designed for 20 types of bacteria in older adults who are hospitalized with suspected community-acquired pneumonia. It aims to see how the vaccine works in real-world care and whether it affects how pneumonia happens or progresses.
This trial studies treatment for pneumonia by enrolling people who have pneumonia signs on a chest X-ray plus typical symptoms like fever, cough, trouble breathing, or chest pain. It may help doctors test approaches for better outcomes after pneumonia.
This study is testing a new way to quickly diagnose severe respiratory infections and find markers that help doctors tell different types apart. It may help get you the right treatment faster.
Hear when a new Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.